167 related articles for article (PubMed ID: 1347773)
1. The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.
Yamanaka Y
Nihon Ika Daigaku Zasshi; 1992 Feb; 59(1):51-61. PubMed ID: 1347773
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study on epidermal growth factor and its receptor in human pancreatic carcinoma].
Yamanaka Y; Onda M; Uchida E; Kobayashi T; Sasajima K; Tokunaga A; Tajiri T; Egami K; Asano G
Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1544-50. PubMed ID: 2214281
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
[TBL] [Abstract][Full Text] [Related]
4. The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma.
Ueda S; Ogata S; Tsuda H; Kawarabayashi N; Kimura M; Sugiura Y; Tamai S; Matsubara O; Hatsuse K; Mochizuki H
Pancreas; 2004 Jul; 29(1):e1-8. PubMed ID: 15211117
[TBL] [Abstract][Full Text] [Related]
5. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
[TBL] [Abstract][Full Text] [Related]
6. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Czyzewska J; Guzinska-Ustymowicz K; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients].
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1181-5. PubMed ID: 1675844
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
Zhang L; Yuan SZ
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
10. The erbB-3 gene in human pancreatic cancer.
Lemoine NR; Lobresco M; Leung H; Barton C; Hughes CM; Prigent SA; Gullick WJ; Klöppel G
J Pathol; 1992 Nov; 168(3):269-73. PubMed ID: 1361525
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression.
Poch B; Gansauge F; Schwarz A; Seufferlein T; Schnelldorfer T; Ramadani M; Beger HG; Gansauge S
Pancreas; 2001 Oct; 23(3):280-7. PubMed ID: 11590324
[TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
13. ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer.
Graber HU; Friess H; Kaufmann B; Willi D; Zimmermann A; Korc M; Büchler MW
Int J Cancer; 1999 Feb; 84(1):24-7. PubMed ID: 9988227
[TBL] [Abstract][Full Text] [Related]
14. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
Kommoss F; Colley M; Hart CE; Franklin WA
Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
[TBL] [Abstract][Full Text] [Related]
15. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
[TBL] [Abstract][Full Text] [Related]
18. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis.
Friess H; Yamanaka Y; Büchler M; Kobrin MS; Tahara E; Korc M
Int J Cancer; 1994 Mar; 56(5):668-74. PubMed ID: 8314343
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor and its receptors in human pancreatic carcinoma.
Chen YF; Pan GZ; Hou X; Liu TH; Chen J; Yanaihara C; Yanaihara N
Pancreas; 1990 May; 5(3):278-83. PubMed ID: 2343041
[TBL] [Abstract][Full Text] [Related]
20. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma.
Feng J; Adsay NV; Kruger M; Ellis KL; Nagothu K; Majumdar AP; Sarkar FH
Pancreas; 2002 Nov; 25(4):342-9. PubMed ID: 12409827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
